参考文献/References:
［1］ Hankey GJ. Stroke［J］. Lancet， 2017， 389： 641- 654.
［2］ Molyneux AJ， Birks J， Clarke A， et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms： 18 year follow- up of the UK cohort of the International Subarachnoid Aneurysm Trial（ISAT）［J］. Lancet， 2015， 385： 691- 697.
［3］ Mascitelli JR， Lawton MT， Hendricks BK， et al. Analysis of wide- neck aneurysms in the barrow ruptured aneurysm trial［J］. Neurosurgery， 2019， 85： 622- 631.
［4］ Bender MT， Wendt H， Monarch T， et al. Shifting treatment paradigms for ruptured aneurysms from open surgery to endovascular therapy over 25 years［J］. World Neurosurg， 2017， 106： 919- 924.
［5］ Muir KW. Stroke in 2015： the year of endovascular treatment［J］. Lancet Neurol， 2016， 15： 2- 3.
［6］ Feng L， Vinuela F， Murayama Y. Healing of intracranial aneurysms with bioactive coils［J］. Neurosurg Clin N Am， 2005， 16： 487- 499.
［7］ Vance A， Welch BG. The utility of bioactive coils in the embolization of aneurysms［J］. Neurol Res， 2014， 36： 356- 362.
［8］ 吴 曦， 刘建民， 黄清海， 等． 第一代Matrix弹簧圈治疗颅内动脉瘤的安全性及中长期随访结果分析［J］． 介入放射学杂志， 2008，17： 384- 388．
［9］ Pierot L， Cognard C， Ricolfi F， et al. Mid- term anatomic results after endovascular treatment of ruptured intracranial aneurysms with Guglielmi detachable coils and Matrix coils： analysis of the CLARITY series［J］. AJNR Am J Neuroradiol， 2012， 33： 469- 473.
［10］ Niimi Y， Song J， Madrid M， et al. Endosaccular treatment of intracranial aneurysms using matrix coils： early experience and midterm follow- up［J］. Stroke， 2006， 37： 1028- 1032.
［11］ Ansari SA， Dueweke EJ， Kanaan Y， et al. Embolization of intra-cranial aneurysms with second- generation Matrix- 2 detachable coils： mid- term and long- term results［J］. J Neurointerv Surg， 2011， 3： 324- 330.
［12］ Fargen KM， Blackburn S， Carpenter JS， et al. Early results of the Axium MicroFX for endovascular repair of IntraCranial Aneurysm（AMERICA） study： a multicenter prospective observational registry［J］. J Neurointerv Surg， 2014， 6： 495- 499.
［13］ Fargen KM， Blackburn S， Deshaies EM， et al. Final results of the multicenter， prospective Axium MicroFX for endovascular repair of IntraCranial Aneurysm study（AMERICA）［J］. J Neurointerv Surg， 2015， 7： 40- 43.
［14］ 李秀山， 李 涛， 李 彬． 铂金弹簧圈与HydroCoil治疗未破裂颅内动脉瘤的疗效比较［J］． 卒中与神经疾病， 2017， 24：512- 515．
［15］ Serafin Z， Di Leo G， Palys A， et al. Follow- up of cerebral aneurysm embolization with hydrogel embolic system： systematic review and meta- analysis［J］. Eur J Radiol， 2015， 84： 1954- 1963.
［16］ Dabus G， Hacein- Bey L， Varjavand B， et al. Safety， immediate and mid- term results of the newer generation of hydrogel coils in the treatment of ruptured aneurysms： a multicenter study［J］. J Neurointerv Surg， 2017， 9： 419- 424.
［17］ Bendszus M， Bartsch AJ， Solymosi L. Endovascular occlusion of aneurysms using a new bioactive coil： a matched pair analysis with bare platinum coils［J］. Stroke， 2007， 38： 2855- 2857.
［18］ Molyneux AJ， Clarke A， Sneade M， et al. Cerecyte coil trial angiographic outcomes of a prospective randomized trial comparing endovascular coiling of cerebral aneurysms with either cerecyte or bare platinum coils［J］. Stroke， 2012， 43： 2544- 2550.
［19］ Liebig T， Henkes H， Fischer S， et al. Fibered electrolytically detachable Platinum coils used for the endovascular treatment of intracranial aneurysms. Initial experiences and mid- term results in 474 aneurysms［J］. Interv Neuroradiol， 2004， 10： 5- 26.
［20］ Raymond J， Klink R， Chagnon M， et al. Hydrogel versus bare platinum coils in patients with large or recurrent aneurysms prone to recurrence after endovascular treatment： a randomized controlled trial［J］. AJNR Am J Neuroradiol， 2017， 38： 432- 441.
［21］ Broeders JA， Ahmed Ali U， Molyneux AJ， et al. Bioactive versus bare Platinum coils for the endovascular treatment of intracranial aneurysms： systematic review and meta- analysis of randomized clinical trials［J］. J Neurointerv Surg， 2016， 8： 898- 908.
［22］ Zhu Y， Zhang H， Zhang Y， et al. Endovascular metal devices for the treatment of cerebrovascular diseases［J］. Adv Mater， 2019， 31： e1805452.
［23］ Wiemer M， Stoikovic S， Samol A， et al. Third generation drug eluting stent （DES） with biodegradable polymer in diabetic patients： 5 years follow- up［J］. Cardiovasc Diabetol， 2017， 16： 23.
［24］ Tank VH， Ghosh R， Gupta V， et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease： a meta- analysis［J］. J Neurointerv Surg， 2016， 8： 770- 774.
［25］ Ye G， Yin X， Yang X， et al. Efficacy and safety of drug- eluting stent for the intracranial atherosclerotic disease： a systematic review and meta- analysis［J］. J Clin Neurosci， 2019， 59： 112- 118.
［26］ Saatci I， Cekirge HS， Ozturk MH， et al. Treatment of internal carotid artery aneurysms with a covered stent： experience in 24 patients with mid- term follow- up results［J］. AJNR Am J Neuro-radiol， 2004， 25： 1742- 1749.
［27］ 李明华．一种新型的脑动脉瘤血管内治疗技术——脑血管覆膜支架术的问世［J］． 介入放射学杂志， 2010， 19： 253- 256．
［28］ Gu Y， Gu B， Li Y， et al. Endovascular treatment of blood blister- like aneurysms in the internal carotid artery using a Willis covered stent［J］. J Intervent Med， 2018， 1： 157- 163.
［29］ Wang W， Li MH， Li YD， et al. Reconstruction of the internal carotid artery after treatment of complex traumatic direct carotid- cavernous fistulas with the willis covered stent： a retrospective study with long- term follow- up［J］. Neurosurgery， 2016， 79：794- 805.
［30］ Wang J， An Q， Li D， et al. Heparin and vascular endothelial growth factor loaded poly（l- lactide- co- caprolactone） nanofiber covered stent- graft for aneurysm treatment［J］. J Biomed Nano-technol， 2015， 11： 1947- 1960.
［31］ Liu P， Liu Y， Li P， et al. Rosuvastatin- and heparin- loaded poly（l- lactide- co- caprolactone） nanofiber aneurysm stent promotes endothelialization via vascular endothelial growth factor type A modulation［J］. ACS Appl Mater Interfaces， 2018， 10： 41012- 41018.
［32］ Zhang Y， Wang J， Xiao J， et al. An electrospun fiber- covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention［J］. Acta Biomater， 2019， 94： 295- 305.
［33］ Walcott BP， Stapleton CJ， Choudhri O， et al. Flow diversion for the treatment of intracranial aneurysms［J］. JAMA Neurol， 2016， 73： 1002- 1008.
［34］ Becske T， Brinjikji W， Potts MB， et al. Long- term clinical and angiographic outcomes following Pipeline embolization device treatment of complex internal carotid artery aneurysms： five- year results of the Pipeline for Uncoilable or Failed Aneurysms trial［J］. Neurosurgery， 2017， 80： 40- 48.
［35］ Lin N， Lanzino G， Lopes DK， et al. Treatment of distal anterior circulation aneurysms with the Pipeline embolization device： a US multicenter experience［J］. Neurosurgery， 2016， 79： 14- 22.
［36］ Girdhar G， Andersen A， Pangerl E， et al. Thrombogenicity assessment of Pipeline Flex， Pipeline Shield， and FRED flow diverters in an in vitro human blood physiological flow loop model［J］. J Biomed Mater Res A， 2018， 106： 3195- 3202.
［37］ Martinez- Galdamez M， Lamin SM， Lagios KG， et al. Periproce-dural outcomes and early safety with the use of the Pipeline Flex embolization device with shield technology for unruptured intracranial aneurysms： preliminary results from a prospective clinical study［J］. J Neurointerv Surg， 2017， 9： 772- 776.
［38］ Martinez- Galdamez M， Lamin SM， Lagios KG， et al. Treatment of intracranial aneurysms using the Pipeline Flex embolization device with shield technology： angiographic and safety outcomes at 1- year follow- up［J］. J Neurointerv Surg， 2019， 11： 396- 399.
［39］ Manning NW， Cheung A， Phillips TJ， et al. Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemor-rhage： multicentre experience［J］. J Neurointerv Surg， 2019， 11： 694- 698.
［40］ Goertz L， Dorn F， Kraus B， et al. Safety and efficacy of the derivo embolization device for the treatment of ruptured intracra-nial aneurysms［J］. J Neurointerv Surg， 2019， 11： 290- 295.
［41］ Kraus B， Goertz L， Turowski B， et al. Safety and efficacy of the Derivo embolization device for the treatment of unruptured intracranial aneurysms： a multicentric study［J］. J Neurointerv Surg， 2019， 11： 68- 73.
［42］ Wang W， Wang YL， Chen M， et al. Magnesium alloy covered stent for treatment of a lateral aneurysm model in rabbit common carotid artery： an in vivo study［J］. Sci Rep， 2016， 6： 37401.
［43］ Zhang E， Shen F. Blood compatibility of a ferulic acid（FA）- eluting PHBHHx system for biodegradable magnesium stent application［J］. Mater Sci Eng C Mater Biol Appl， 2015， 52： 37- 45.
［44］ Wang J， He Y， Maitz MF， et al. A surface- eroding poly（1，3- trime- thylene carbonate）coating for fully biodegradable magnesium- based stent applications： toward better biofunction， biodegradation and biocompatibility［J］. Acta Biomater， 2013， 9： 8678- 8689.
［45］ Ahmadi Lakalayeh G， Rahvar M， Haririan E， et al. Comparative study of different polymeric coatings for the next- generation magnesium- based biodegradable stents［J］. Artif Cells Nanomed Biotechnol， 2018， 46： 1380- 1389.
［46］ Korin N， Gounis MJ， Wakhloo AK， et al. Targeted drug delivery to flow- obstructed blood vessels using mechanically activated nanotherapeutics［J］. JAMA Neurol， 2015， 72： 119- 122.
［47］ Kuang H， Wang Y， Hu J， et al. A method for preparation of an internal layer of artificial vascular graft co- modified with salvianolic acid B and heparin［J］. ACS Appl Mater Interfaces， 2018， 10： 19365- 19372.
［48］ Wu HL， Li YH， Lin YH， et al. Salvianolic acid B protects human endothelial cells from oxidative stress damage： a possible protective role of glucose- regulated protein 78 induction［J］. Cardiovasc Res， 2009， 81： 148- 158.
［49］ Leng B， Tang F， Lu M， et al. Astragaloside Ⅳ improves vascular endothelial dysfunction by inhibiting the TLR4/NF- κB signaling pathway［J］. Life Sci， 2018， 209： 111- 121.
［50］ Fang H， Yang S， Luo Y， et al. Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation，migration and neointimal hyper-plasia through PI3K/Akt signaling［J］. Sci Rep， 2018， 8： 7595.
相似文献/References:
[1]吕在刚,王琳娜,陈晓辉,等.脑血管病伴糖尿病患者介入治疗后对比剂对肾功能的影响 [J].介入放射学杂志,2018,27(03):277.
LV Zaigang,WANG Linna,CHEN Xiaohui,et al.Effect of contrast media on renal function in patients with cerebrovascular disease complicated by diabetes mellitus after receiving interventional treatment[J].journal interventional radiology,2018,27(07):277.